Estimations des analystes de Wall Street pour Oramed Pharmaceuticals Inc. (ORMP): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 6 |
| Conserver | 2 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 8 |
| Note moyenne (1-5) | 0.75 |
Ratios de valorisation
| Ratio P/E | 1.09 |
| Prix / Valeur comptable | 0.60 |
| EV / EBITDA | 1.26 |
| Rendement du dividende | 5.41% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $641000 | $2.5M | $2.4M | $2.7M | $2.7M | $2.7M | $2.7M | $1.3M | 0 | $2.0M |
| Coût des Ventes | $490000 | $187000 | $86000 | $90000 | 0 | 0 | 0 | 0 | 0 | $2.0M |
| Marge Brute | $151000 | $2.3M | $2.4M | $2.6M | $2.7M | $2.7M | $2.7M | $1.3M | 0 | $13000 |
| R&D | $7.7M | $10.3M | $12.0M | $13.5M | $10.2M | $21.0M | $27.6M | $9.0M | $6.3M | $6.4M |
| Frais Généraux | $2.5M | $2.8M | $4.1M | $3.7M | $4.2M | $5.9M | $15.7M | $8.1M | $6.5M | $8.7M |
| Charges Opérationnelles | $10.2M | $13.0M | $16.1M | $17.2M | $14.5M | $26.9M | $43.3M | $17.1M | $12.8M | $15.1M |
| Résultat Opérationnel | -$10.0M | -$10.8M | -$13.5M | -$14.6M | -$11.8M | -$24.2M | -$40.6M | -$15.8M | -$12.8M | -$15.1M |
| EBITDA | -$10.0M | -$10.8M | -$13.5M | -$14.2M | -$11.8M | -$24.1M | -$37.0M | $7.3M | -$14.9M | $75.4M |
| Charges d'Intérêt | $11000 | $6000 | $6000 | 0 | 0 | 0 | 0 | $3.6M | $853000 | 0 |
| Résultat Avant Impôts | -$9.6M | -$10.1M | -$12.7M | -$14.1M | -$11.5M | -$23.0M | -$37.7M | $5.1M | -$15.9M | $75.3M |
| Impôts | $1.3M | $400000 | -$800000 | $300000 | 0 | 0 | $100000 | 0 | $3.2M | $11.3M |
| Résultat Net | -$11.0M | -$10.5M | -$12.7M | -$14.4M | -$11.5M | -$22.2M | -$37.8M | $5.5M | -$19.1M | $64.0M |
| BPA | $-0.87 | $-0.79 | $-0.86 | $-0.82 | $-0.56 | $-0.78 | $-0.97 | $0.14 | $-0.48 | $1.53 |
| BPA Dilué | $-0.87 | $-0.79 | $-0.86 | $-0.82 | $-0.56 | $-0.78 | $-0.97 | $0.14 | $-0.48 | $1.50 |
| Actions en Circulation (Diluées) | $12.6M | $13.3M | $14.9M | $17.5M | $20.5M | $28.5M | $39.0M | $40.6M | $40.9M | $42.4M |
Prix
| Prix | $4.62 |
| Capitalisation | $189M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: CLNN · CNTB · CNTX · COYA · IFRX · IMA · KLRS
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ORMP: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions